Case report: dramatic recovery of lung adenocarcinoma-associated dermatomyositis with targeted lung cancer therapy alone.
This case report details the sudden onset of severe dermatomyositis (DM) symptoms followed by rapid progression of adenocarcinoma of the lung and an obvious diminution of the primary tumor with the administration of lung cancer targeted drug therapy alone, followed by nearly complete disappearance of the DM symptoms, with no conspicuous improvement in the DM symptoms when using corticosteroids.
Zang
Yuan-Sheng
YS
Department of Respiratory Medicine, Changzheng Hospital, Second Military Medical University, Shanghai, China.
Xiu
Qing-Yu
QY
Fang
Zheng
Z
Li
Bing
B
Xia
Tian-Bao
TB
D000230:Adenocarcinoma / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D000970:Antineoplastic Agents / Q000627:therapeutic use; D003882:Dermatomyositis / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D000077156:Gefitinib; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D008875:Middle Aged; D010257:Paraneoplastic Syndromes / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D011799:Quinazolines / Q000627:therapeutic use; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D005938:Glucocorticoids; D011799:Quinazolines; D000077156:Gefitinib